Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yili Pharmaceutical (Luoding) is a major pharmaceutical manufacturing subsidiary of the Yili Pharmaceutical Group, specializing in the production of traditional Chinese medicine (TCM) and chemical drugs. Based in Luoding, Guangdong, the company operates a modern production facility equipped with advanced lines for tablets, capsules, granules, and oral liquids. Its extensive product portfolio covers therapeutic areas such as respiratory health, anti-inflammatory treatments, gastroenterology, and pediatrics, featuring flagship products like Chuanwang Xiaoyan Tablets and Fuyankang Capsules. As a recognized high-tech enterprise, the company focuses on integrating traditional herbal expertise with modern pharmaceutical standards and extraction technologies. Yili Pharmaceutical (Luoding) serves as a critical production hub for the group, distributing its products across the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yili Pharmaceutical Luoding.